Abstract
Pulmonary Kaposi’s sarcoma is a frequent complication of human immunodeficiency virus (HIV) infection. This chapter will discuss pulmonary Kaposi’s sarcoma in the context of HIV disease in terms of epidemiology, pathogenesis, presentation and diagnosis. Current therapeutic approaches will also be outlined as will new potential treatments that may supercede our present management of this difficult condition.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ammann, A.J., Palladino, MA., Voldberding, P. et al., (1987) Alpha and beta tumour necrosis factor in acquired immunodeficiency syndrome and the AIDS related complex. Journal of Clinical Immunology, 7, 481–5.
Antinorri, A., Immacolata, I., Ammassari, A. et al. (1992) Evaluation of different staging systems of Kaposi’s sarcoma in HIV infected patients. Journal of Cancer Research Clinical Oncology, 118, 635–6.
Barillari, G., Buonagura, L., Fiorelli, V. et al. (1992) Cytokines from activated immune cells on vascular cell growth and genome expression. Journal of Immunology, 149, 3727–34.
Bernstein, Z.P., Wilson, D., Summers, K. et al. (1995) Pilot/Phase I study of photodynamic therapy in the treatment of AIDS related Kaposi’s sarcoma. Proceedings of ASCO, 14, 289.
Beral, V., Peterman, T.A., Berkelman, R.L., and Jaffe, H.W. (1990) Kaposi’s sarcoma among persons with AIDS: a sexually transmitted infection? Lancet, 335, 123–8.
Broderick, P.A., and Krinsley, J.S. (1990) Transbronchial biopsy in Kaposi’s sarcoma. Connecticut Medicine, 54, 555–7.
Burgess, W.H., and Macaig, T. (1989) The heparin binding (fibroblast) growth factor family of proteins. Annual Review of Biochemistry, 58, 575–62.
Buscombe, J.R., Oyen, W.J.G., Grant, A. et al. (1993) Indium-111 labeled polyclonal human immunoglobulin: Identifying focal infection in patients positive for HIV. Journal of Nuclear Medicine, 34, 1621–25.
Bussolino, F., Ziche, M., Wang, J.M. et al. (1991) In vitro and in vivo activation of endothelial cells by colony stimulating factors. Journal of Clinical Investigation, 87, 986–95.
Chang, Y., Cesarman, E., Pessin, M.S. et al. (1994) Identification of herpesvirus like sequences in AIDS associated Kaposi’s sarcoma. Science, 266, 1865–9.
Corbeil, J., Rappaport, E., Richman, D.D., Cooney, D.J. et al. (1994) Anti-proliferative effect of retinoid compounds in Kaposi’s sarcoma. Journal of Clinical Investigation, 93, 1981–6.
Dinarello, C.A. (1991) Interleukinl and intereukinl antagonism. Blood, 77, 1627–34.
Denton, A.S., Miller, R.F., and Spittle, M.F. (1995) Management of pulmonary Kaposi’s sarcoma: new perspectives. British Journal of Hospital Medicine, 53, 344–50.
Denton, A.S., Simpson, J.K., Hallam, M.H. et al. (1996) Effects on pulmonary function of two regimens of chemotherapy for AIDS related Kaposi’s sarcoma. Clinical Oncology, 8, 48–50.
Ensoli, B., Nakamura, S., Salahuddin, S.Z. et al. (1989) AIDS-Kaposi’s sarcoma derived cells express cytokines with autocrine and paracrine growth effects. Science, 243, 223–6.
Ensoli, B., Barillari, G., Salahuddin, S.Z. et al. (1990) The tat protein of HIV 1 stimulates growth of cells derived from Kaposi’s sarcoma lesions of AIDS patients. Nature, 345, 84–86.
Ensoli, B., Barillari, G., and Gallo, R.C. (1992) Cytokines and growth factors in the pathogenesis of AIDS associated Kaposi’s sarcoma. Immunological Reviews, 127, 147–55.
Friedman-Kien, A.E. (1984) Kaposi’s sarcoma is an opportunistic neoplasm. Journal of Investigative Dermatology, 82, 446–48.
Gill, P.S., Rarick, M.U., Montgomery, T. et al. (1990) Acquired immunodeficiency syndrome related Kaposi’s sarcoma. Cancer, 65, 1074–8.
Gallant, J.E., Moore, R.D., Richman, D.D. et al. (1994) Risk factors for Kaposi’s sarcoma in patients with advanced HIV treated with zidovudine: zidovudine epidemiology study group. Archives of Internal Medicine, 154, 56–672.
Gompels, M.M., Hill, A., Jenkins, P. et al. (1992) Kaposi’s sarcoma in HIV infection treated with bleomycin and vincristine. AIDS, 6, 1175–80.
Gunton, C.F., Roth, E.L., and Von Roem, J.H. (1993) Raynaud’s phenomenon in bleomycin containing chemotherapies. Cancer, 72, 20046.
Huang, Y.Q., Li, J.J., Rush, M.G. et al. (1992) Human papilloma virus type 16-related DNA sequences in Kaposi’s sarcoma. Lancet, 339, 515–18.
Hoover, D.R., Black, C., Jacobson, L.P. et al. (1993) Analysis of Kaposi’s sarcoma as an early or late outcome in HIV affected men. American Journal of Epidemiology, 138, 226–78.
Hughes-Davies, L., Kocjan, G., Spittle, M.F., and Miller, R.F. (1992) Occult alveolar haemorrhage in pulmonary Kaposi’s sarcoma. Journal of Clinical Pathology, 45, 536–7.
Ireland-Gill, A., Espina, B.M., Akil, B., and Gill, P.K. (1991) Treatment of AIDS related Kaposi’s sarcoma containing bleomycin in various regimens. Seminars in Oncology, 19, Suppl 5, 32–39.
Kilmas, N.G. (1992) Clinical impact of adoptive therapy with purified CD8 cells in HIV infection. Seminars in Haematology, 29, (supplement 1), 40–43.
Koech, D.K., and Obel, A.O. (1990) Efficiency of low dose oral natural human interferon alpha in the management of HIV1 infection in AIDS. East African Medical Journal, 67, 64–68.
Krigel, R., Laubenstein, L., Muggia, F. et al. (1983) Kaposi’s sarcoma: a new staging classification. Cancer Treatment Reports, 67, 531–4.
Krown, S.E., Metroka, C., Wernz, J.C. et al. (1989) AIDS Clinical Trials Group oncology committee: Kaposi’s sarcoma in the acquired immune deficiency syndrome; A proposal for uniform evaluation, response and staging criteria. Journal of Clinical Oncology, 7, 1201–7.
Krown, S.E., Paredes, J., Bundow, D. et al. (1992) Alpha-IFN, AZT and GMCSF; a phase 1 clinical trial in Kaposi’s sarcoma associated with AIDS. Journal of Clinical Oncology, 10, 1344–51.
Krown, S.E., Paredes, J., Polsky, B. et al. (1995) Phase I/II trial of soluble recombinant interleukin 1 receptor in patients with HIV infection. Proceedings of ASCO, 14, 292.
Martin, R.W., Hood, A.F., and Farmer, E.R. (1993) Kaposi’s sarcoma. Medicine, 72 (4) 1, 245–61.
Meduri, G.U., and Stein, D.S. (1992) Pulmonary manifestations of acquired immune deficiency syndrome. Clinical Infectious Diseases, 14, 98–113.
Meduri, G.U., Stover, D.E., Lee, M. et al. (1986) Pulmonary Kaposi’s sarcoma in acquired immunodeficiency syndrome. American Journal of Medicine, 81, 11–18.
Meyer, J.H. (1993) Whole lung radiotherapy in pulmonary Kaposi’s sarcoma. American Journal of Clinical Oncology, 16, 372–6.
Miller, R.F., Tomlinson, M.C., Cottril, C.P. et al. (1992) Bronchopulmonary Kaposi’s sarcoma in patients with AIDS. Thorax, 47, 721–25.
Mitchell, D.M., and Miller, R.F. (1992) Developments in the management of pulmonary complications of HIV disease. Thorax, 47, 381–90.
Money-Kyrle, J.F., Bates, F., Ready, J. et al. (1993) Efficacy of liposomal daunorubicin in the treatment of AIDS related Kaposi’s sarcoma. Clinical Oncology, 5, 367–71.
Moss, F., Flemming, J., Nelson, J. et al. (1989) Palatal KS is a strong predictor of pulmonary involvement. Thorax, 44, 326 P.
Nair, B.C., DeVico, A.L., Nakamura, S. et al. (1992) Identification of a major growth factor for AIDS Kaposi’s sarcoma cells as oncostatin M. Science, 255, 1430–2.
Nathan, S., Vaghaiwalla, R., Monsenfor, Z. et al. (1990) Use of the Nd:YAG laser in endobronchial Kaposi’s sarcoma. Chest, 98, 1299–300.
Niedt, G.W., Myskowsky, P.L., Urmacher, C. et al. (1992) Histological predictors of survival in Kaposi’s sarcoma. Human Pathology, 23, 141–926.
Northfelt, D.W., Robles, R., Lang, W. et al. (1995) Phase I/II study of intravenous recombinant PF4 in AIDS related Kaposi’s sarcoma. Proceedings of ASCO, 14, 289.
Pluda, J.M., Shay, L.E., Foly, N.K. et al. (1993) Administration of pentosan to HIV related Kaposi’s sarcoma. Journal of the National Cancer Institute, 85, 1585–92.
Pluda, J.M., Wyvill, K., Figg, W.D. et al. (1994) A phase 1 study of angiogenesis inhibition with TNP470 administered to HIV patients with associated Kaposi’s sarcoma. Proceedings of ASCO, 13, 51.
Remmick, S.C., Reddy, M., and Hermin, D. et al. (1994) Infusional bleomycin as a treatment for AIDS related Kaposi’s sarcoma. Journal of Clinical Oncology, 12, 1130–6.
Santucci, M., Pimpinelli, N., Moretti, S. et al. (1988) Classical and immunodeficiency associated Kaposi’s sarcoma. Clinical histological and immunological correlations. Archives of Pathology and Laboratory Medicine, 112, 1214–20.
Schwartzmann, G., Mans, D.R.A., Machado, V.L. et al. (1995) Phase II study of bFGF inhibiting agent pentosan polysulphate in patients with AIDS related Kaposi’s sarcoma. Proceedings of ASCO, 14, 290.
Saville, M.W., Pluda, J.M., Fenerstein, I. et al. (1995) Treatment of HIV associated Kaposi’s sarcoma with paclitaxel (Taxol). Lancet, 346, 26–28.
Simpson, J.K., Miller, R.F., and Spittle, M.F. (1993) Liposomal doxorubicin in the treatment of AIDS related Kaposi’s sarcoma. Clinical Oncology, 5, 372–4.
Wassie, E., Buscombe, J.R., Miller, R.F., and Ell, P.J. (1992) Ga scintigraphy in HIV positive patients: a review of its clinical usefulness. British Journal of Radiology, 67, 349–52.
Weindel, K., Marme, D., Weich, H.A. et al. (1992) AID-associated Kaposi’s sarcoma cells in culture express vascular endothelial growth factor. Biochemical and Biophysical Research Communications, 183, 167–74.
White, D.A., and Matthay, R.A. (1989) Non infectious pulmonary complications of infection with the human immunodeficiency virus. American Review of Respiratory Disease, 140, 1763–87.
Wolff, S.D., Kuhlman, J.E., Fishman, E.K. et al. (1993) CT findings of Thoracic Kaposi’s sarcoma in acquired immune deficiency syndrome. Journal of Computer Assisted Tomography, 17, 60–62.
Zhang, Y.M., Backmann, S., Hemmer, C. et al. (1994) Vascular origin of Kaposi’s sarcoma. American Journal of Pathology, 144, 51–59.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Denton, A.S., Spittle, M.F. (1997). Kaposi’s Sarcoma — Clinical Features. In: Zumla, A., Johnson, M., Miller, R. (eds) AIDS and Respiratory Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3446-8_18
Download citation
DOI: https://doi.org/10.1007/978-1-4899-3446-8_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-60140-8
Online ISBN: 978-1-4899-3446-8
eBook Packages: Springer Book Archive